Toxicity Profile of Intensity-Modulated Radiation Therapy for Head and Neck Carcinoma and Potential Role of Amifostine

Seminars in Oncology

Volumn 30, Issue 6 SUPPL. 18, 2003, Pages 101-108

  Chao, K S Clifford ^a   Ozyigit, Gokhan ^b   Thorsdad, Wade L ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; FLUOROURACIL; PACLITAXEL; PLATINUM DERIVATIVE;

ADOLESCENT; ADULT; AGED; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; FRACTIONATION; HEAD AND NECK CARCINOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MUCOSA INFLAMMATION; NAUSEA; PAROTID GLAND; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SALIVATION; SIDE EFFECT; TREATMENT OUTCOME; XEROSTOMIA;

EID: 1642476545     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2003.11.009     Document Type: Conference Paper

References (29)

1. Provide author names: Intensity-modulated radiotherapy: Current status and issues of interest. Int J Radiat Oncol Biol Phys 51:880-914, 2001
2. Tubiana M, Eschwege F: Conformal radiotherapy and intensity-modulated radiotherapy: Clinical data. Acta Oncol 39:555-567, 2000
3. Eisbruch A, Kim HM, Terrell JE, et al: Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 50:695-704, 2001
4. Eisbruch A, Foote RL, O'Sullivan B, et al: Intensity-modulated radiation therapy for head and neck cancer: Emphasis on the selection and delineation of the targets. Semin Radiat Oncol 12:238-249, 2002
5. Chao KS, Majhail N, Huang CJ, et al: Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: A comparison with conventional techniques. Radiother Oncol 61:275-280, 2001
6. Chao KS, Deasy JO, Markman J, et al: A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results. Int J Radiat Oncol Biol Phys 49:907-916, 2001
7. Chao KS: Protection of salivary function by intensity-modulated radiation therapy in patients with head and neck cancer. Semin Radiat Oncol 12:20-25, 2002
8. Antonadou D, Pepelassi M, Synodinou M, et al: Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer. Int J Radiat Oncol Biol Phys 52:739-747, 2002
9. Bourhis J, De Crevoisier R, Abdulkarim B, et al: A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 46:1105-1108, 2000
10. Brizel DM, Wasserman TH, Henke M, et al: Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18:3339-3345, 2000
11. Buntzel J, Kuttner K, Frohlich D, et al: Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer. Ann Oncol 9:505-509, 1998
12. Chao KS, Wippold FJ, Ozyigit G, et al: Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 53:1174-1184, 2002
13. Chao KS, Ozyigit G, Tran BN, et al: Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 55:312-321, 2003
14. Ozyigit G, Chao KS: Clinical experience of head-and-neck cancer IMRT with serial tomotherapy. Med Dosim 27: 91-98, 2002
15. Butler EB, Teh BS, Grant WH III, et al: SMART (simultaneous modulated accelerated radiation therapy) boost: A new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 45:21-32, 1999
16. Rooney M, Kish J, Jacobs J, et al: Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer 55:1123-1128, 1985
17. The Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690, 1991
18. Taylor SG IV, Applebaum E, Showel JL, et al: A randomized trial of adjuvant chemotherapy in head and neck cancer. J Clin Oncol 3:672-679, 1985
19. Maor MH, Berkey B, Forastiere AA, et al: Larynx preservation and tumor control in stage III and IV laryngeal cancer: A three-arm randomized intergroup trial; RTOG 91-11. Int J Radiat Oncol Biol Phys 54:2-3, 2002 (suppl 1)
20. Browman GP, Hodson DI, Mackenzie RJ, et al: Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis. Head Neck 23:579-589, 2001
21. El-Sayed S, Nelson N: Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol 14:838-847, 1996
22. Beumer J III, Curtis T, Harrison RE: Radiation therapy of the oral cavity: Sequelae and management, part 2. Head Neck Surg 1:392-408, 1979
23. Beumer J III, Curtis T, Harrison RE: Radiation therapy of the oral cavity: Sequelae and management, part 1. Head Neck Surg 1:301-312, 1979
24. Harrison LB, Zelefsky MJ, Pfister DG, et al: Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck 19:169-175, 1997
25. Eisbruch A, Ship JA, Kim HM, et al: Partial irradiation of the parotid gland. Semin Radiat Oncol 11:234-239, 2001
26. Eisbruch A, Dawson LA, Kim HM, et al: Conformal and intensity modulated irradiation of head and neck cancer: The potential for improved target irradiation, salivary gland function, and quality of life. Acta Otorhinolaryngol Belg 53:271-275, 1999
27. Braaksma M, Levendag P: Tools for optimal tissue sparing in concomitant chemoradiation of advanced head and neck cancer: Subcutaneous amifostine and computed tomography-based target delineation. Semin Oncol 29:63-70, 2002
28. Dawson LA, Anzai Y, Marsh L, et al: Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 46:1117-1126, 2000
29. Lee N, Xia P, Quivey JM, et al: Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys 53:12-22, 2002